US stock · Healthcare sector · Medical Devices
Company Logo

Align Technology, Inc.

ALGNNASDAQ

222.36

USD
-6.45
(-2.82%)
Market Closed
25.68P/E
22Forward P/E
1.42P/E to S&P500
17.368BMarket CAP
- -Div Yield
Upcoming Earnings
26 Oct
Shares Short
9/15/22
2.07M
Short % of Float
2.67%
Short % of Shares Outs.
2.65%
% Held by Insiders
6.33%
% Held by Institutions
90.20%
Beta
1.80
PEG Ratio
0.62
52w. high/low
713.33/204.32
Avg. Daily Volume
0.85M
Return %
Stock
S&P 500
1 year
(66.45)
(15.03)
3 years
22.29
27.03
5 years
17.68
47.04
Scale: |
High
Low
29.71
13.07
17.22
4.88
18.85
6.10
21.40
13.18
25.94
14.25
39.82
22.39
60.00
25.61
65.10
43.27
68.48
51.65
102.10
57.31
266.41
88.56
398.88
188.57
334.64
169.84
543.65
127.88
737.45
494.45
658.50
204.50
Currency: USD
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
TTM
Revenue per share
3.26
4.23
4.55
4.52
5.11
6.15
6.95
8.20
9.43
10.57
13.52
18.40
24.56
30.30
31.39
50.19
50.70
Earnings per share
(0.55)
0.53
1.20
(0.45)
0.98
0.86
0.73
0.80
1.81
1.80
2.38
2.89
5.00
5.57
22.55
9.80
7.86
FCF per share
(0.60)
0.68
0.38
0.97
1.47
1.28
1.19
2.07
2.51
2.31
2.22
3.03
4.14
7.52
6.44
14.89
10.03
Dividends per share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
CAPEX per share
0.38
0.11
0.21
0.10
0.24
0.39
0.48
0.24
0.30
0.67
0.88
2.44
2.79
1.88
1.97
- -
3.66
Book Value per sh.
1.32
2.40
3.27
3.95
4.98
6.29
7.22
7.87
9.32
10.60
12.46
14.36
15.65
16.95
41.06
46.00
45.76
Comm.Shares outs.
63
67
67
69
76
78
81
81
81
80
80
80
80
79
79
79
79
Avg. annual P/E ratio
(16.8)
39.2
9.1
(26.4)
17.9
25.1
40.9
51.1
29.9
33.2
34.1
55.7
58.3
44.5
13.6
62.8
25.7
P/E to S&P500
(0.9)
2.3
0.4
(0.4)
0.9
1.5
2.8
3.0
1.6
1.7
1.5
2.4
2.3
1.8
0.4
2.1
1.4
Avg. annual div. yield
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue (m)
206
284
304
312
387
480
560
660
762
845
1,080
1,473
1,966
2,407
2,472
3,953
3,990
Operating margin
(18.2)%
11.9%
5.1%
(10.9)%
26.5%
18.8%
15.3%
14.3%
25.4%
22.3%
23.1%
24.0%
23.7%
22.5%
15.7%
24.7%
21.7%
Depreciation (m)
10
13
13
13
14
17
18
17
18
18
24
38
55
79
94
- -
88
Net profit (m)
(35)
36
80
(31)
74
67
59
64
146
144
190
231
400
443
1,776
772
619
Income tax rate
(2.4)%
3.3%
(368.4)%
7.7%
27.2%
25.8%
30.4%
31.0%
23.4%
22.6%
21.1%
35.7%
12.4%
20.0%
(368.6)%
23.7%
26.9%
Net profit margin
(16.9)%
12.6%
26.3%
(10.0)%
19.2%
13.9%
10.5%
9.7%
19.1%
17.0%
17.6%
15.7%
20.4%
18.4%
71.8%
19.5%
15.4%
Working capital (m)
40
123
117
180
296
237
330
369
455
460
599
659
610
662
524
570
572
Long-term debt (m)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
64
103
98
Equity (m)
84
161
219
273
378
491
581
634
753
848
995
1,150
1,253
1,346
3,234
3,623
3,599
ROIC
(41.7)%
22.1%
36.6%
(11.4)%
19.3%
13.3%
9.8%
9.8%
18.5%
16.2%
18.2%
18.2%
29.5%
29.0%
50.7%
19.2%
15.4%
Return on capital
(22.5)%
16.6%
6.1%
(9.5)%
21.4%
13.9%
11.1%
11.2%
19.3%
16.1%
17.3%
20.3%
22.3%
22.2%
7.8%
17.0%
14.5%
Return on equity
(41.8)%
22.2%
36.6%
(11.5)%
19.7%
13.6%
10.1%
10.1%
19.4%
17.0%
19.1%
20.1%
31.9%
32.9%
54.9%
21.3%
17.2%
Plowback ratio
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
100.0%
Div.&Repurch./FCF
- -
(63.9)%
156.0%
- -
(10.6)%
(17.7)%
5.1%
36.6%
39.5%
49.0%
46.6%
36.8%
85.5%
63.9%
(4.0)%
- -
45.9%
Capital Structure
4 Aug · 2022 | Q2
All numbers in millions
Total liabilities
$ 2,211
Total assets
$ 5,810
Long-term debt
$ 98
Cash and equiv.
$ 878
Goodwill
$ 390
Retained earnings
$ 2,602
Common stock
78
Enterprise Value
$ 16,589
Working Capital
Currency: USD, in millions
2019
2020
2021
Cash & Investments
869
961
1,171
Receivables
621
708
897
Inventory
112
139
230
Other
32
452
744
Current assets
1,633
1,850
2,494
Acc. Payable
87
142
164
Debt due
16
22
- -
Other
868
1,162
1,760
Current liabilities
971
1,326
1,924
Annual growth rates
(avg. rate of change)
1 year
5 years
10 years
Revenue
59.90%
29.62%
25.21%
Cash flow
131.15%
58.21%
39.24%
Earnings
(56.53)%
82.03%
57.44%
Dividends
- -
- -
- -
Book value
12.02%
42.15%
26.89%
Insider Trading
Type
Shares
Date
Coletti Julie Ann
Exempt
320
07/20/22
Coletti Julie Ann
Exempt
386
07/20/22
Coletti Julie Ann
InKind
309
07/20/22
Coletti Julie Ann
Exempt
706
07/20/22
Siegel Susan E
Award
1,114
05/18/22
Quarterly Revenue
Currency: USD, in millions
Year
1Q
2Q
3Q
4Q
Total
2020
551
352
734
835
2,472
2021
895
1,011
1,016
1,031
3,953
2022
973
970
- -
- -
- -
Earnings per share
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
19.28
(0.52)
1.77
2.02
22.55
2021
2.54
2.54
2.30
2.42
9.80
2022
1.71
1.44
- -
- -
- -
Quarterly dividends paid
Currency: USD
Year
1Q
2Q
3Q
4Q
Total
2020
- -
- -
- -
- -
- -
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
Company Description
Sector:
Healthcare
Industry:
Medical Devices
CEO:
Mr. Joseph Hogan
Full-time employees:
24,020
City:
San Jose
Address:
2820 Orchard Pkwy
IPO:
Jan 26, 2001
Website:
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Recent News